SAT-611 The Effects of Omega-3 on T1DM Population: A Systematic Review and Meta-Analysis

Abstract Disclosure: R. Jain: None. A. Desai: None. D. Venkataraman: None. R. Montanarin: None. R. Kleimmann: None. K. Raj: None. Background- Omega-3 polyunsaturated fatty acids (Omega-3) have antioxidant properties and have been shown to improve a variety of disease processes such as diabetes, cardiovascular disease. However, the impact of Omega-3, in the treatment and management of type 1 diabetes mellitus (T1DM) remains unclear. Therefore, this report presents an updated meta-analysis on the efficacy of Omega-3 supplementation on the glycemic control (HbA1C), lipid profile and vascular health in T1DM patients. Methods- EMBASE, PubMed, and Cochrane databases were searched up to July 2024 for randomized controlled trials (RCTs) and observational studies comparing Omega-3 and placebo in patients with T1DM. We pooled outcomes for 1) HbA1C, 2) triglycerides, 3) LDL, 4) HDL, 5) total cholesterol and 6) carotid intima thickness. Heterogeneity was assessed with I² statistics. A random-effects model was used for outcomes with high heterogeneity. Results- 5 RCTs and 1 cohort study with 261 patients were included, of whom 119 were given Omega-3. Mean follow up ranged from 3 months up to 12 months. HbA1c (SMD -0.56; 95% CI -0.89 - -0.22, p<0.01 ; I² = 0%Figure 1A) and triglycerides (SMD -0.81; 95% CI -1.53 - -0.08, p = 0.005; I² = 77%; Figure 1B) was reduced in the Omega-3 group after 3 months. HDL levels (SMD 1.47 ; 95% CI 0.12 - 2.82, p = 0.00009; I² = 92%) were raised in the Omega-3 group after 3 months. Carotid intima thickness (SMD -0.68; 95% CI -1.33 - -0.03, p = 0.04; I² = 69%) was also reduced in the intervention group after 3 months. Conclusion- Our findings suggest that Omega-3 in the T1DM population is associated with reduction of HbA1C, and Triglycerides levels, even though the LDL and total cholesterol remain unchanged. It also increases HDL cholesterol and reduces carotid intima thickness. Presentation: Saturday, July 12, 2025

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.1137
Primary Topic
Fatty Acid Research and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SAT-611 The Effects of Omega-3 on T1DM Population: A Systematic Review and Meta-Analysis

Journal of the Endocrine Society
Fatty Acid Research and Health
article

SAT-611 The Effects of Omega-3 on T1DM Population: A Systematic Review and Meta-Analysis

article en

Abstract

Abstract Disclosure: R. Jain: None. A. Desai: None. D. Venkataraman: None. R. Montanarin: None. R. Kleimmann: None. K. Raj: None. Background- Omega-3 polyunsaturated fatty acids (Omega-3) have antioxidant properties and have been shown to improve a variety of disease processes such as diabetes, cardiovascular disease. However, the impact of Omega-3, in the treatment and management of type 1 diabetes mellitus (T1DM) remains unclear. Therefore, this report presents an updated meta-analysis on the efficacy of Omega-3 supplementation on the glycemic control (HbA1C), lipid profile and vascular health in T1DM patients. Methods- EMBASE, PubMed, and Cochrane databases were searched up to July 2024 for randomized controlled trials (RCTs) and observational studies comparing Omega-3 and placebo in patients with T1DM. We pooled outcomes for 1) HbA1C, 2) triglycerides, 3) LDL, 4) HDL, 5) total cholesterol and 6) carotid intima thickness. Heterogeneity was assessed with I² statistics. A random-effects model was used for outcomes with high heterogeneity. Results- 5 RCTs and 1 cohort study with 261 patients were included, of whom 119 were given Omega-3. Mean follow up ranged from 3 months up to 12 months. HbA1c (SMD -0.56; 95% CI -0.89 - -0.22, p<0.01 ; I² = 0%Figure 1A) and triglycerides (SMD -0.81; 95% CI -1.53 - -0.08, p = 0.005; I² = 77%; Figure 1B) was reduced in the Omega-3 group after 3 months. HDL levels (SMD 1.47 ; 95% CI 0.12 - 2.82, p = 0.00009; I² = 92%) were raised in the Omega-3 group after 3 months. Carotid intima thickness (SMD -0.68; 95% CI -1.33 - -0.03, p = 0.04; I² = 69%) was also reduced in the intervention group after 3 months. Conclusion- Our findings suggest that Omega-3 in the T1DM population is associated with reduction of HbA1C, and Triglycerides levels, even though the LDL and total cholesterol remain unchanged. It also increases HDL cholesterol and reduces carotid intima thickness. Presentation: Saturday, July 12, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Universidade Tecnológica Federal do Paraná (BR), Topiwala National Medical College & BYL Nair Charitable Hospital (IN), Appalachian Regional Healthcare (US), Davao Medical School Foundation (PH), Universidade Federal do Paraná (BR)
Good health and well-being
Openalex Percentile: Top 43%
Fatty Acid Research and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.